Plain answers
The questions people actually ask - answered in plain English, with links to check the facts yourself. Nothing here is medical advice.
Select a topic category to narrow down questions.
Not exactly. The review is about whether pharmacies may legally compound these substances — building a legal, regulated pathway, not adding a new prohibition. Today most already have no cleared legal channel. Follow the status on the tracker.
It's documented. Independent testing of falsified peptide products has found purity ranging from roughly 5% to 75%, plus arsenic and lead above injectable-drug limits, and the FDA has reported hospitalizations from dosing errors with unregulated injectable product. The danger isn't the molecule in the abstract - it's not knowing what's actually in the vial. See the sourced figures in By the Numbers and how to stay safe in Safety.
Most are not FDA-approved drugs and have no cleared legal pathway for compounding, so they aren't lawfully sold for human use. That's why online sellers label them "research use only / not for human consumption" - a workaround the FDA has targeted in warning letters. Legality is precisely what this review is about.
On July 23-24, 2026, an FDA advisory committee reviews seven peptides and votes a recommendation on whether licensed pharmacies should be allowed to compound them. That vote is advisory and non-binding - a recommendation, not a final rule. See exactly where each one stands on the tracker.
No. Peppies does not sell, promote, or facilitate the sale of any peptide, and makes no money from their sale. It's an independent education and advocacy resource. Read our full position on the About page.
Get notified
The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.
